Advertisement

Topics

Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 19032019] Prices from USD $175

23:41 EDT 13 Jun 2019 | BioPortfolio Reports

Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Astex Pharmaceuticals, Inc. Astex or the company', a member of Otsuka Group, is involved in the discovery, development and commercialization of cancer and central nervous system CNS therapies. It offers oncology product portfolio with multiple drugs in midlate stage clinical development worldwide and CNS product portfolio of novel targeted therapeutics for defined neurodegenerative disease populations. Astex performs its discovery research from its research facility in the UK, while carries out product development activities from the US facility. Astex was formed after the merger of Astex Therapeutics Ltd. and SuperGen, Inc in 2011. In 2013, the company was acquired by Otsuka Group. It is headquartered in Pleasanton, California, the US.


Scope


Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis

An indepth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Astex Pharmaceuticals, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Original Article: Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 19032019] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Astex Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 19032019] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...